AiDER in the media
A European project develops an imaging tool to improve radiotherapy for cancer
The AIDER initiative seeks to revolutionise targeted therapy with radioactive atoms, optimising dosimetry and treatment safety in cancer patients.
Advanced Imaging DEtector for targeted Radionuclide therapy
Targeted radionuclide therapy (TRT) uses radiopharmaceuticals to selectively deliver radiation to cancerous cells at specific target organs. A precise quantification of the radiation dose delivered to lesions and organs at risk is crucial for improving patient treatment safety and reducing related side effects. Imaging systems play a key role in this task although, in many cases, with sub-optimal performance.
New initiative in the fight against cancer: IFIC coordinates the European AIDER project
A team from the Institute of Corpuscular Physics (IFIC), a joint centre of the Spanish National Research Council (CSIC) and the University of Valencia (UV), is leading a new initiative to fight cancer through medical physics.
New European project to combat cancer using radiopharmaceutical therapy
The Institute of Corpuscular Physics (IFIC, CSIC-UV) is leading a new initiative to fight cancer through medical physics. The project, called AIDER, is coordinated by researcher Gabriela Llosá and aims to develop a medical imaging tool for targeted therapy using radioactive atoms or radionuclides. Four European academic groups, a company, two hospitals and a patient association form the consortium that will collaborate on this project for four years.
Scientists from Valencia lead pioneering project using radioactive atoms to fight cancer
The AIDER initiative seeks to revolutionise targeted therapy with radioactive atoms, optimising dosimetry and treatment safety in cancer patients.